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Abstract
The acute and chronic effects of whole-body vibration (WBV) on balance, postural stability, and mobility were evaluated in
21 women with relapsing-remitting multiple sclerosis (MS) randomly assigned to control (n¼ 9) or experimental (n¼ 12) groups.
To assess acute responses, outcome variables were assessed before and immediately after a session of WBV (five 30-second
bouts of vibration; frequency 30 Hz; amplitude 3 mm; 1-minute rest intervals) during their first visit (week 1) using field (Timed-Up
and Go; 500-m walk; Berg Balance Scale) and laboratory tests (NeuroCom Balance Master and EquiTest System—Sensory
Organization Test, Adaptation Test, Limits of Stability, Modified Clinical Test for Sensory Integration of Balance, Unilateral Stance,
Tandem Walk, Step/Quick Turn). Acute responses were also measured after their fifth visit for only the Adaptation and Sensory
Organization tests. For the chronic responses, participants were exposed to the WBV protocol once a week, for a total of
5 weeks, and then at week 5, were reassessed with the Adaptation and the Sensory Organization tests. Neither acute nor chronic
exposure to the WBV protocols used in this study resulted in significant improvements (P > .05) in balance, postural stability, or
mobility as assessed by either field or laboratory tests. However, based on promising results from other studies that have used
WBV with other clinical populations, either alone or in conjunction with exercise, additional studies that increase the dose of
vibration exposure, both acutely and chronically, should be conducted in patients with MS.
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Introduction
Multiple sclerosis (MS) is a chronic, inflammatory, and neuro-
degenerative disease of the central nervous system, which is
characterized by immune-mediated inflammation with second-
ary demyelination and potential axonal loss.1 The most preva-
lent symptoms of MS include fatigue, weakness, hypertonia,
incoordination, balance and gait dysfunction, and vision and
sensory impairments.2 Reductions in muscular strength, power,
and endurance are also commonly observed and can result in a
reduced ability to perform activities of daily living.3 Muscle
performance deficits are thought to be due to incomplete motor
unit recruitment and decreased motor unit discharge as well as
changes in muscle fibers consistent with disuse atrophy.4
Ataxia and balance disorders are very incapacitating problems
in patients with MS, are multifactorial in origin, and include
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weakness, spasticity, proprioceptive loss, and cerebellar
dysfunction.
Traditional resistance and aerobic exercise protocols have
been shown to effectively diminish functional impairments in
MS5-7; however, reductions in motor control associated with
MS may limit the feasibility of traditional resistance exercise in
patients with MS. Therefore, alternative interventions, such as
whole-body vibration (WBV), are being examined as potential
modalities for moderating MS symptoms.
The WBV protocols typically require the participant to
stand or sit on a vibration platform while receiving a mechan-
ical stimulus imparted by the device. Although the precise
mechanisms explaining improved neuromuscular performance
following WBV remain unclear, it has been suggested that the
mechanical stimuli imparted through the body stimulate the
endings of muscle spindles, leading to an activation of alpha
motor neurons to facilitate muscle contractions.8 Therefore,
WBV application has become increasingly popular as both
prophylactic and therapeutic interventions to enhance muscular
performance in both healthy young individuals, elderly9-11 and
clinical populations.12 Additionally, compared to resistance
exercise, WBV may serve as a safer alternative for augmenting
neuromuscular performance in patients with MS displaying
impaired motor control.
The evaluation of WBV as a potential therapeutic interven-
tion for MS was first explored by Schuhfried et al13 who
observed significant improvements in mobility (Timed-Up and
Go [TUG] performance) and postural stability lasting 1 week
after an acute exposure of WBV (5 bouts of vibration at 2.0-4.4
Hz frequency, 3 mm amplitude, with 1-minute rest periods
between exposures). Thereafter, several additional investiga-
tions have been conducted with contradictory results on the
efficacy of WBV.14-16 Claerbout et al17 performed a 3-week,
10-session study that had patients perform exercises while
standing on a vibration platform (vertical vibrations with a
1.6 mm amplitude, 30-40 Hz frequency) and observed signif-
icant improvements in muscular strength but no changes were
detected in functional performance outcomes, whereas Broek-
mans et al18 conducted a 20-week study (5 sessions every 2
weeks) that involved patients performing static and dynamic
squats and lunges on a vibration platform (25-45 Hz, 2.5 mm
amplitude) and observed no changes in lower extremity
strength or functional performance in patients with MS. Cumu-
latively, regarding measures of functional performance, some
WBV interventions have reported no changes,17-19 while other
studies have reported significant improvements.20,21 Based on
the variations in vibration protocols (durations, frequencies,
amplitudes, etc) and the conflicting results, this warrants fur-
ther examination regarding the effectiveness of WBV for
improving functional status in MS populations. Furthermore,
to our knowledge, no previous investigations have explored the
influence of WBV on postural control, balance measures, or
mobility in MS populations. Evidence from previous literature
documenting improvements in balance and postural control
following WBV in paralleling neurological disorders such as
cerebral palsy, Parkinson disease, and stroke,22-24 supports the
examination of WBV on balance, postural control, and mobi-
lity in MS populations. Kantele et al15 highlighted that the
results indicating possible benefits of WBV training to
patients with MS are limited by methodological issues, which
include confounding factors such as additional exercises per-
formed in combination with WBV. Therefore, the purpose of
this investigation was to examine the acute and chronic effects
of WBV exposure on balance, postural control, and mobility
in women with MS following 5 weeks of once-weekly WBV
training. To the best of our knowledge, this will be the first
study to investigate both the acute and chronic effects of
WBV in patients with MS. We hypothesized that a 5-week




Twenty-one women aged from 18 to 64 years (46.6 [9.6] years;
1.6 [0.1] m; 72.6 [15.5] kg) diagnosed with relapsing-remitting
MS, not using any assistive devices, and not involved in any
resistance or endurance training programs, volunteered to par-
ticipate in the current study. All participants were previously
diagnosed with MS by a board-certified neurologist according
to the McDonald criteria.25
Study Design
This study investigated the effects of acute (prior to and fol-
lowing a single bout of WBV at week 1 and week 5 of the
intervention) and chronic (1 bout of WBV each week for
5 weeks) WBV exposure on balance, mobility, and postural
control in women diagnosed with MS (Figure 1). Participants
were randomly assigned by using an online number generator
(www.random.org) to either an intervention (WBV: n ¼ 12)
or a control (CON: n ¼ 9) group. During visit 1 (week 1),
study procedures were explained to the participants and writ-
ten informed consent for participation was completed. The
baseline measurements for all the outcome variables were
then assessed for all participants in the following order: Sen-
sory Organization Test (SOT), Adaptation Test (ADP), Limits
of Stability (LOS), Modified Clinical Test for Sensory Inte-
gration of Balance (mCT-SIB), Unilateral Stance (US), Tan-
dem Walk (TW), Step/Quick Turn (SQT), TUG, 500-m walk,
and Berg Balance Scale (BBS). This order of assessment was
maintained throughout the study. Participants in the WBV
group were then exposed to a session of WBV and reassessed
immediately after the bout of WBV (first acute session). Dur-
ing visits 2, 3, and 4 (weeks 2, 3, and 4), participants were
exposed to the WBV protocol, but no pre- or postvibration
assessments were carried out. At visit 5 (week 5), participants
were submitted to another bout of WBV exposure and as in
visit 1 and were assessed for all outcome variables prior to and
following the WBV exposure. All testing during the entire
study was done by the same investigator.
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Study Procedures
Whole-body vibration. Whole-body vibration was applied using a
vibration platform (PowerPlate; Next Generation, Northbrook,
Illinois) at a frequency of 30 Hz and a fixed low amplitude set
at 3 mm (approximately 2.2 g acceleration). Each participant in
the WBV group was exposed to 5 bouts of vibration that lasted 30
seconds each and with a rest interval of 1 minute between bouts.
Participants were asked to stand barefoot on the platform with feet
shoulder width apart and to adopt a squat position, which required
a slight flexion of the hip, knee, and ankle joints. Participants were
instructed to hold on to the supportive bars that are part of the
vibration platform, which would also vibrate whenever the plat-
form was turned on, so that the upper body would also receive the
vibration stimulus. Participants in the CON group did not receive
any vibration stimuli, but they were required to stand on the plat-
form in the same squat position and for the same amount of time as
the participants in the WBV group. All assessments were per-
formed immediately post vibration exposure with an average 3-
minute period from the WBV exposure to the first measurement
for both acute and chronic effects.
Field Tests
Timed-Up and Go test. The TUG test was used to measure mobi-
lity. Participants were asked to raise up from sitting in a chair to
a standing position and to walk a distance of 10 m, turn around,
walk back to the chair, and sit down again with their backs
flush to the back of the chair and with arms resting on the arm
rests. The time for participants to complete the task was mea-
sured in seconds with a stopwatch. The best, or lowest time
from 3 trials, was used in the analyses.
The 500-m walk. The 500-m walk was used to assess mobility
by measuring the time, in minutes, to walk 500 m. A 62.5 m
straight line was traced on the floor and participants were
asked to walk as fast as possible through the length of the line
8 times. The timing started as participants initiated the walk
and ended as soon as they finished the eighth lap and only one
trial was performed.
Berg Balance Scale. The BBS was used to measure balance.26 The
scale consists of 14 tasks with a 5-point scale, ranging from 0 to
4, with 0 indicating the lowest and 4 the highest level of function.
The highest possible score is 56 and the scale includes both
balance and mobility tasks. Each participant was asked to per-
form all the 14 tasks to the best of their ability. The 14 tasks
included: (1) sit to standing, (2) standing unsupported, (3) sitting
unsupported, (4) stand to sitting, (5) transfers, (6) standing with
eyes closed (EC), (7) standing with feet together, (8) reaching
forward with outstretched arms, (9) retrieving an object from the
floor, (10) turning to look behind, (11) turning 360, (12) placing
alternate feet on a stool, (13) standing with one foot in front, and
(14) standing on one foot. The tester recorded the appropriate
score for each test based on each participant’s performance.
There was only one trial of each measure and the combined
score out of 56 was used in the analyses.
Laboratory Tests
Sensory Organization Test. The SOT was performed using a
NeuroCom Balance Master (NeuroCom International Inc,
Clackamas, OR) and the EquiTest System (v8.0). This test
measures the participants’ ability to make effective use of
visual, vestibular, and proprioceptive information to maintain
balance. It provides an equilibrium score (ES%) that reflects
the amount of sway in both anterior and posterior directions.
Higher scores indicate greater stability and less sway. The
support surface that participants stood on and/or the visual
surroundings moved or swayed in response to a participants’
sway during the test (sway-referenced). There were 6 different
testing conditions for the SOT: (1) normal vision (eyes open
[EO]) with fixed floor; (2) EC with fixed floor; (3) EO, fixed
surroundings and floor sways; (4) EC, fixed surroundings and
floor sways; (5) EO, surroundings sway and fixed floor; and (6)
EO, both surroundings and floor sways. Before testing, parti-
cipants were strapped into a harness that was attached to a
support beam and positioned on the fixed platform in proper
alignment according to the computer screen to ensure that their
center of gravity was in the center of the screen. Participants
were asked to stand as still and stable as possible during each
test and each testing condition was measured 3 times with the
highest, or best score used in the analyses.
Adaptation Test. The ADP was performed using a NeuroCom
Balance Master and the EquiTest System to analyze the motor
system’s ability to adapt to platform movements that caused the
ankles to rotate resulting in the participants toes to go up or
down, without causing displacement of the participant’s center
of gravity. This test provided a nondimensional sway energy
score (SES) that quantified how well participants were able to
minimize anteroposterior platform rotations, based on the velo-
city and acceleration of the center of pressure. Participants were
Figure 1. Scheme of the study design.
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exposed to a series of 5 consecutive rotations for each cycle of
toes up or toes down and the lowest, or best score was used in the
analyses. A smaller SES would represent a greater ability to
react more efficiently. Participants were asked to keep their
EO and to look straight ahead while standing upright as steady
as possible. A computer screen located in front of the partici-
pants displayed foot placement and indicated when trial sessions
were over. Participants were instructed to maintain their balance
during a disruptive somatosensory input caused by unexpected
changes in the orientation of the support surface. This test pro-
vides information regarding standing and walking on uneven
surfaces.
Limits of Stability. The LOS test was performed on the NeuroCom
Balance Master and EquiTest System with participants secured
in the harness to assess the ability to voluntarily sway to different
points in space and to maintain that position. The parameter
examined was directional control, or the amount of movement
in the intended direction toward the target compared to the
amount of extraneous movement away from the target and
expressed as a percentage. The higher the percentage score (clo-
sest to 100%), the greater the directional control. There were 8
trials for this test: (1) forward, (2) forward-right, (3) right, (4)
backward-right, (5) backward, (6) backward-left, (7) left, and (8)
forward left, and each trial lasted 8 seconds. While strapped into
the harness, participants began with their actual center of gravity
being observed on the computer screen in front of them, and as
their center of gravity shifted, the cursor which represented them
also moved on the computer screen. The goal was to lean accu-
rately and quickly in order for the cursor to coincide with one of
the 8 targets (trials) on the screen and to maintain that position
for 8 seconds before returning to the neutral starting position and
await the next trial. Only one trial of each condition was per-
formed and the percentage score obtained from each condition
was used in the analyses. This test could provide information
concerning adaptation abnormalities that could occur with lower
limb biomechanical and/or vestibular system and central ner-
vous system problems affecting balance.
Modified Clinical Test for Sensory Integration of Balance. The mCT-
SIB was conducted on the NeuroCom Balance Master’s 5 ft
(1.5 m) long, flat dual force plate to assess stability or postural
sway velocity (/s) on hard or soft surfaces with EO or EC.
There were 4 testing conditions, each lasting 10 seconds. The
first 2 conditions took place on a hard surface with EO and EC
and the last 2 conditions were on a foam surface with EO and
EC. Participants were instructed to keep their EO or EC and
look straight ahead while standing in an upright position
remaining as still as possible. In all conditions, a low score
indicated less sway and more stability, whereas a high score
indicated more sway and less stability. There were 3 trials of
each condition performed and the best or lowest score from
each condition was used in the analyses. In order to project
good balance, an individual must hold their center of gravity
near the center of their base of support. This test attempts to
identify abnormalities in the sensory system contributions to
postural control by distinguishing between normal, abnormal,
and severely abnormal individuals.
Unilateral Stance. The US test was assessed on the same Neu-
roCom Balance Master flat force plate that was used for the
mCT-SIB. The US test was measured with participants stand-
ing on the force plate using only one foot and postural stability
was quantified by assessing postural sway velocity (/s), with
greater sway velocities indicating greater instability. There
were 3 trials (10 seconds each) in each of the 4 testing condi-
tions: (1) balancing on the right foot with EO or (2) EC and
(3) balancing on the left foot with EO or (4) EC. The best, or
lowest score for each condition, was used in the analyses.
Tandem Walk. The TW test was used to analyze gait and bal-
ance (gait speed measured in cm/s and end point sway velocity
measured in  /s) as participants walked heel-to-toe along the
flat force plate of the NeuroCom Balance Master. While
standing on one end of the force plate with heel-to-toe
touching, the participants were instructed to stand as steady
as possible until they heard the word “go.” They were then
asked to walk as fast and safely as possible, heel-to-toe, to
the other end of the force plate and remain steady. Once
finished, they returned the starting point on the opposite
side of the force plate and repeated the test 2 additional
times. The best, or highest speed and the best, or lowest
sway velocity scores were used in the analyses. Low sway
velocities are good and provide some information of neck,
trunk, and hip extensor strength.
Step/Quick Turn. This test was used to measure balance (mean
turn sway in degrees) as participants pivoted 180 after taking 2
steps forward and then returning back to the starting position on
the NeuroCom long force plate. This test consisted of 3 trials
with the right foot leading and 3 trials with the left foot leading
and the best, or lowest, scores were used in the analyses. The
test started with the participants standing in the upright posi-
tion at the end of the force platform. Once the test started, the
participants quickly took 2 steps forward beginning with
either the left or the right foot and then pivoted, either turning
to the left or right, and returned to the starting position and
remained steady for 5 seconds. This test provides information
regarding possible somatosensory loss, trunk and lower extre-
mity weaknesses, vestibular deficiencies, or asymmetrical
lower extremities.
Statistical Analysis
Acute responses (pre vs post) to WBV at week 1 (TUG, 500-m
walk, BBS, SOT, ADP, LOS, mCT-SIB, US, TW, and SQT)
and week 5 (SOT and ADP) were analyzed with a 2-way
repeated-measures analysis of variance (ANOVA) (group [con-
trol and WBV]  time [pre and post]). To evaluate the chronic
effects of WBV, percentage change scores from the acute ses-
sions at week 1 and week 5 (SOT and ADP) were analyzed with
a 2-way repeated-measures ANOVA (group [control and
WBV]  time [week 1 and week 5]). Chronic effects of WBV
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(SOT and ADP) were also evaluated with a complete model
that involved a 2-way repeated-measures ANOVA (group
[control and WBV]  time [pre-week 1, post-week 1, pre-
week 5, and post-week 5]). The level of significance was set
as P < .05 and all statistical analyses were carried out using




Regarding responses to a single bout of WBV at week 1, no
significant main effects for time (P > .05) or group (P > .05),
nor significant group  time interactions (P > .05), were
observed for the TUG test, 500-m walk test, BBS, or for any
of the 6 conditions of the SOT (Table 1).
For the ADP at week 1, there were significant main effects
for group (P ¼ .049) and time (P ¼ .003) but no significant
group  time interaction for the toes up testing condition. The
CON group had significantly lower or better scores than the
WBV group across both time points, and postscores were sig-
nificantly lower or better than prescores for both groups. For
the toes down condition, there were no significant main effects
for group (P > .05) or time (P > .05) and no significant group
time interaction (P > .05; Table 2). Similarly, there were no
significant main effects for group (P > .05) or time (P > .05)
and no significant group  time interaction (P > .05) for the 8
testing conditions of the LOS test (Table 2) at week 1.
Table 3 presents the results for the mCT-SIB and the US test
at week 1. There were no significant main effects for group (P
> .05) or time (P > .05) and no significant group  time inter-
action (P > .05) for any of the 8 testing conditions for the mCT-
SIB. Similarly, there were no significant main effects for group
(P > .05) or time (P > .05) and no significant group  time
interaction (P > .05) for any of the US conditions observed
at week 1.
Results for the TW test and SQT at week 1 are displayed in
Table 4. There were no significant main effects for group or
time (P > .05) and no significant group  time interaction
(P > .05) for the end point sway velocity (/s) parameter for
the TW test. For the speed parameter of the TW test, there was
no significant main effect for group (P > .05) and no significant
group  time interaction (P > .05), but there was a significant
main effect for time (P ¼ .003), with postmeasures being sig-
nificantly greater than premeasures. Table 4 also illustrates the
results for the 2 parameters of the SQT. There were no signif-
icant main effects for group (P > .05) or time (P > .05) and no
significant group  time interaction (P > .05) for either the
right or left turn sway parameters of the 2 parameters of the
SQT at week 1 (Figure 1).
The acute effects of WBV for the ADP and SOT at week 5
are presented in Table 5. Similar to week 1, a significant main
effect for time (P ¼ .003) was observed for the toes up condi-
tion, with premeasures across both groups being significantly
greater than postmeasures; however, no significant main
effects for group (P > .05) or significant group  time interac-
tion (P > .05) were observed for the same condition. For the
toes down condition, there were no significant main effects for
group (P > .05) or time (P > .05) and no significant group 
time interaction (P > .05). There were significant main effects
for time with EO, fixed floor condition (P ¼ .002), as well as
Table 1. Acute Effects of WBV Exposure on Timed-Up and Go, 500-m Walk, Berg Balance Scale, and Sensory Organization Tests at Week 1.
Variable Exp. N Pre Post Group Time Group  Time
TUG test (seconds) WBV 12 7.78 (1.67) 8.29 (1.84) P ¼ .735 P ¼ .219 P ¼ .421
CON 9 8.25 (1.67) 8.36 (2.23) Z2p ¼ .06 Z2p ¼ .08 Z2p ¼ .03
500-m walk (minutes) WBV 12 5.78 (1.64) 5.34 (1.33) P ¼ .535 P ¼ .566 P ¼ .118
CON 9 5.10 (0.91) 5.31 (1.31) Z2p ¼ .02 Z2p ¼ .02 Z2p ¼ .12
BBS WBV 12 53.42 (3.18) 53.50 (3.17) P ¼ .894 P ¼ .400 P ¼ .400
CON 9 53.67 (3.94) 53.67 (3.94) Z2p < .01 Z
2
p ¼ .04 Z2p ¼ .04
SOT EO (%) WBV 12 91.83 (6.48) 92.50 (6.16) P ¼ .409 P ¼ .599 P ¼ .792
CON 9 93.89 (3.55) 94.11 (3.14) Z2p ¼ .04 Z2p ¼ .02 Z2p < .01
SOT EC (%) WBV 12 87.75 (9.87) 88.00 (12.30) P ¼ .727 P ¼ .558 P ¼ .408
CON 9 90.00 (6.34) 88.56 (4.98) Z2p < .01 Z
2
p ¼ .02 Z2p ¼ .04
SOT FL EO (%) WBV 11 79.73 (9.23) 84.55 (6.30) P ¼ .792 P ¼ .439 P ¼ .353
CON 9 81.44 (7.81) 81.00 (14.56) Z2p < .01 Z
2
p ¼ .03 Z2p ¼ .05
SOT FL EC (%) WBV 11 64.55 (9.47) 66.72 (9.51) P ¼ .478 P ¼ .206 P ¼ .818
CON 8 61.00 (12.13) 64.13 (12.67) Z2p ¼ .03 Z2p ¼ .92 Z2p < .01
SOT SUR (%) WBV 12 87.25 (14.89) 88.25 (7.42) P ¼ .577 P ¼ .377 P ¼ .697
CON 9 88.67 (8.25) 91.22 (3.27) Z2p ¼ .02 Z2p ¼ .04 Z2p ¼ .01
SOT SUR-FL (%) WBV 12 66.33 (16.42) 66.75 (12.82) P ¼ .634 P ¼ .887 P ¼ .730
CON 8 64.00 (14.70) 63.00 (13.31) Z2p ¼ .01 Z2p < .01 Z2p < .01
Abbreviations: TUG, Timed-Up and Go—lower scores indicate greater mobility; 500-m walk—lower scores indicate greater mobility; BBS, Berg Balance Scale—
higher scores indicate greater level of function; SOT, Sensory Organization Test—higher scores indicate greater stability; SUR, surroundings sway; FL, floor sways;
SUR-FL, both floor and surroundings sway; EO, eyes open; EC, eyes closed; WBV, whole-body vibration.
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for the EO, surroundings sway and fixed floor condition
(P ¼ .009), indicating that postequilibrium scores decreased
from prescores across both conditions. There were no
significant main effects for group (P > .05) or time (P > .05)
or group  time interactions (P > .05) for the remaining 4
conditions of the SOT.
Table 3. Acute Effects of WBV Exposure on the Modified Clinical Test for Sensory Integration of Balance and the Unilateral Stance Test at
Week 1.
Variable Exp. N Pre Post Group Time Group  Time
Firm—EO (/s) WBV 12 0.25 (0.23) 0.26 (0.21) P ¼ .587 P ¼ .356 P ¼ .577
CON 9 0.19 (0.15) 0.22 (0.20) Z2p ¼.02 Z2p ¼.05 Z2p ¼ .02
Firm—EC (/s) WBV 12 0.31 (0.23) 0.34 (0.25) P ¼.515 P ¼.838 P ¼ .314
CON 9 0.27 (0.28) 0.24 (0.22) Z2p ¼.02 Z2p <.01 Z2p ¼ .05
Foam—EO (/s) WBV 12 0.86 (0.36) 0.89 (0.28) P ¼.338 P ¼.320 P ¼ .169
CON 9 0.83 (0.58) 0.63 (0.20) Z2p ¼.05 Z2p ¼.05 Z2p ¼ .01
Foam—EC (/s) WBV 12 1.43 (0.70) 1.32 (0.45) P ¼.218 P ¼.411 P ¼ .973
CON 9 1.16 (0.57) 1.06 (0.40) Z2p
¼.08 Z2p ¼.04 Z2p < .01
US—RL: EO (/s) WBV 12 0.93 (0.49) 0.78 (0.38) P ¼.275 P ¼.250 P ¼ .376
CON 9 2.06 (3.76) 0.93 (0.42) Z2p ¼.06 Z2p ¼.07 Z2p ¼ .04
US—RL: EC (/s) WBV 12 3.79 (4.96) 2.86 (4.29) P ¼.474 P ¼.875 P ¼ .134
CON 9 1.58 (1.11) 2.72 (3.69) Z2p ¼.02 Z2p <.01 Z2p ¼ .11
US—LL: EO (/s) WBV 12 2.15 (3.23) 0.98 (0.53) P ¼.870 P ¼.110 P ¼ .865
CON 9 2.19 (3.70) 1.23 (1.01) Z2p <.01 Z
2
p ¼.13 Z2p < .01
US—LL: EC (/s) WBV 12 2.23 (3.17) 3.72 (5.00) P ¼.938 P ¼.130 P ¼ .771
CON 9 2.60 (3.57) 3.62 (4.76) Z2p <.01 Z
2
p ¼.12 Z2p < .01
Abbreviations: WBV, whole-body vibration; CON, control; mCT-SIB, Modified Clinical Test for Sensory Integration of Balance tests—lower scores indicate
greater stability; US, Unilateral Stance—lower scores indicate greater stability; EO, eyes open; EC, eyes closed; LL, left leg; RL, right leg.
Table 2. Acute Effects of WBV Exposure on the Adaptation and Limits of Stability Tests at Week 1.
Variable Exp. n Pre Post Group Time Group  Time
ADP TU (SES) WBV 12 66.50 (22.49)a,b 58.50 (14.97)b P ¼ .049 P ¼ .003 P ¼ .935
CON 9 51.63 (10.41)a 44.00 (7.98) Z2p ¼ .20 Z2p ¼ .40 Z2p < .01
ADP TD (SES) WBV 12 49.25 (15.67) 46.75 (10.83) P ¼ .167 P ¼ .299 P ¼ .798
CON 9 43.22 (13.54) 39.11 (10.27) Z2p ¼ .01 Z2p ¼ .06 Z2p < .01
LOS-R (%) WBV 11 81.64 (6.83) 83.09 (4.74) P ¼ .150 P ¼ .144 P ¼ .486
CON 9 73.33 (13.96) 77.33 (16.61) Z2p ¼ .11 Z2p ¼ .12 Z2p ¼ .03
LOS-L (%) WBV 11 81.55 (6.24) 80.82 (5.98) P ¼ .689 P ¼ .350 P ¼ .583
CON 8 83.75 (9.21) 81.00 (8.67) Z2p ¼ .01 Z2p ¼ .05 Z2p ¼ .02
LOS-F (%) WBV 12 79.00 (25.16) 81.17 (11.78) P ¼ .473 P ¼ .112 P ¼ .279
CON 9 69.67 (19.07) 80.56 (8.73) Z2p ¼ .03 Z2p ¼ .13 Z2p ¼ .06
LOS-FL (%) WBV 12 76.50 (11.23) 77.00 (13.90) P ¼ .486 P ¼ .826 P ¼ .933
CON 8 72.13 (17.26) 73.25 (18.26) Z2p ¼ .03 Z2p < .01 Z2p < .01
LOS-FR (%) WBV 12 77.83 (15.04) 82.00 (6.88) P ¼ .622 P ¼ .157 P ¼ .939
CON 8 75.75 (11.93) 79.50 (11.01) Z2p ¼ .01 Z2p ¼ .11 Z2p < .01
LOS-B (%) WBV 8 69.88 (13.87) 71.50 (10.86) P ¼ .185 P ¼ .217 P ¼ .139
CON 7 69.57 (93.38) 52.86 (28.92) Z2p ¼ .13 Z2p ¼ .12 Z2p ¼ .16
LOS-BR (%) WBV 11 65.27 (14.65) 63.45 (19.64) P ¼ .087 P ¼ .555 P ¼ .373
CON 6 48.17 (19.61) 57.00 (12.81) Z2p ¼ .18 Z2p ¼ .02 Z2p ¼ .05
LOS-BL (%) WBV 11 54.64 (17.39) 60.18 (15.89) P ¼ .395 P ¼ .309 P ¼ .968
CON 7 48.57 (23.90) 54.57 (14.47) Z2p ¼ .05 Z2p ¼ .06 Z2p < .01
Abbreviations: WBV, whole-body vibration; CON, control; ADP, Adaptation Test—lower scores indicate greater balance; TU, toes Up; TD, toes down; SES, sway
energy score; LOS, Limits of Stability test—higher scores indicate greater directional control; LOS-R, Limits of Stability right; LOS-L, Limits of Stability left; LOS-F,
Limits of Stability forward; LOS-FL, Limits of Stability forward-left; LOS-FR, Limits of Stability forward-right; LOS-B, Limits of Stability backward; LOS-BR, Limits of
Stability backward-right; LOS-BL, Limits of Stability backward–left.
aSignificantly different from post (P < .05).
bSignificantly greater than CON (P < .05).
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Chronic Responses
Figure 2 presents the percentage changes in the SESs from pre-
to postvibration for weeks 1 and 5 for the ADP. No significant
main effects for group (P > .05) or time (P > .05) nor significant
group  time interactions (P > .05) were observed for the ADP
with toes up (Figure 2A) or toes down (Figure 2B).
The percentage changes from pre- to postvibration at weeks
1 and 5 in the equilibrium scores measured in the 6 conditions
of the SOT are illustrated in Figure 3. No significant main
effects for group (P > .05) or time (P > .05) nor significant
group  time interactions (P > .05) were observed for
the following SOT testing conditions: EC fixed floor
(Figure 3B), EC fixed surroundings and floor sways (Figure 3D),
and EO, both surroundings and floor sways (Figure 3F).
Although there were no significant main effects for group
(P > .05) or no significant group  time interactions
(P > .05) for the remaining variables, there were significant
main effects for time (P < .05) for the EO, fixed floor condition
(Figure 3A), the EO, fixed surroundings and floor sways con-
dition (Figure 3C), and for the EO, surroundings sway and
fixed floor condition (Figure 3E). For all these 3 conditions,
significant reductions in the percentage changes for the
equilibrium score were observed at visit 5 compared to visit
1, indicating a poorer performance in maintaining stability.
Table 6 displays the acute (previbration to postvibration)
and chronic changes (from weeks 1 to 5) for both the ADP and
SOT using the full model (group [2] and time points [4]).
Although no significant main effects for group (P > .05) or
time (P > .05) nor no significant group  time interactions (P
> .05) were observed for the toes down condition of the ADP,
a significant main effect for time main (P < .05) was observed
Table 5. Acute Effects of WBV Exposure on the ADP and SOT at Week 5.
Variable Exp. N Pre Post Group Time Group  Time
ADP TU (SES) WBV 12 48.75 (11.73)a 46.42 (11.15) P ¼ .635 P ¼ .016 P ¼ .242
CON 9 48.00 (15.57)a 41.79 (14.93) Z2p ¼ .01 Z2p ¼ .27 Z2p ¼ .07
ADP TD (SES) WBV 12 45.50 (9.32) 43.25 (9.37) P ¼ .304 P ¼ .314 P ¼ .948
CON 9 41.67 (12.41) 39.11 (9.27) Z2p ¼ .06 Z2p ¼ .05 Z2p < .01
SOT EO (%) WBV 12 93.67 (2.46)a 87.75 (10.70) P ¼ .764 P ¼ .002 P ¼ .859
CON 9 94.78 (2.59)a 88.22 (8.34) Z2p < .01 Z
2
p ¼ .40 Z2p < .01
SOT EC (%) WBV 12 89.75 (6.30) 89.33 (6.91) P ¼ .859 P ¼ .986 P ¼ .591
CON 9 89.78 (5.67) 90.22 (4.66) Z2p < .01 Z
2
p < .01 Z
2
p ¼ .02
SOT FL EO (%) WBV 11 77.73 (6.47) 67.27 (11.41) P ¼ .441 P ¼ .301 P ¼ .387
CON 8 67.13 (7.75) 66.63 (14.89) Z2p ¼ .04 Z2p ¼ .06 Z2p ¼ .04
SOT FL EC (%) WBV 12 71.83 (8.94) 68.00 (12.08) P ¼ .983 P ¼ .122 P ¼ .881
CON 8 72.13 (10.32) 67.50 (16.79) Z2p < .01 Z
2
p ¼ .13 Z2p < .01
SOT SUR (%) WBV 12 88.00 (7.63)a 83.42 (9.14) P ¼ .991 P ¼ .009 P ¼ .509
CON 9 89.33 (6.46)a 82.00 (13.50) Z2p < .01 Z
2
p ¼ .31 Z2p ¼ .23
SOT SUR-FL (%) WBV 12 92.58 (4.78) 89.08 (30.66) P ¼ .373 P ¼ .118 P ¼ .281
CON 8 94.13 (3.60) 76.00 (23.00) Z2p ¼ .04 Z2p ¼ .13 Z2p ¼ .06
Abbreviations: WBV, whole-body vibration; CON, control; ADP, Adaptation Test—lower scores indicate greater balance; TU, toes up; TD, toes down; SES, sway
energy score; SOT, Sensory Organization Test—higher scores indicate greater stability; EO, eyes open; EC, eyes closed; SUR, surroundings sway; FL, floor sways;
SUR-FL, both floor and surroundings sway.
aSignificantly different from post (P < .05).
Table 4. Acute Effects of WBV Exposure on Tandem Walk and Step/Quick Turn Tests at Week 1.
Variable Exp. N Pre Post Group Time Group  Time
TW: sway velocity (/s) WBV 12 3.46 (1.20) 3.43 (1.01) P ¼ .921 P ¼ .386 P ¼ .309
CON 9 3.19 (0.69) 3.80 (1.84) Z2p ¼ .01 Z2p ¼ .04 Z2p ¼ .05
TW: speed (cm/s) WBV 12 18.78 (6.67) 26.08 (10.81)a P ¼ .277 P ¼ .003 P ¼ .973
CON 9 22.97 (11.93) 30.41 (10.44)a Z2p ¼ .06 Z2p ¼ .37 Z2p ¼ .01
SQT: right () WBV 12 21.25 (14.15) 20.33 (12.11) P ¼ .865 P ¼ .656 P ¼ .267
CON 9 18.89 (9.11) 21.02 (7.10) Z2p < .01 Z
2
p ¼ .01 Z2p ¼ .06
SQT: left () WBV 12 23.83 (15.21) 20.37 (14.08) P ¼ .423 P ¼ .318 P ¼ .705
CON 9 19.18 (6.16) 17.60 (4.63) Z2p ¼ .03 Z2p ¼ .05 Z2p < .01
Abbreviations: WBV, whole-body vibration; CON, control; TW, Tandem Walk—lower scores indicate greater mobility; SQT, Step/Quick Turn—lower scores
indicate greater mobility.
aPost significantly larger than pre (P < .05).
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for the toes up condition, where all time points were signifi-
cantly lower compared to previbration exposure measures at
week 1 indicating a greater ability to react more efficiently to
minimize anterior–posterior platform rotations. For the EC
and fixed floor condition of the SOT, there were no significant
main effects for group (P > .05) or time (P > .05) and no
significant group  time interaction (P > .05).
Although no significant main effects for group (P > .05) or
no significant group  time interactions were detected for the
other 5 conditions of the SOT, there were significant main
effects for time (P < .05) for each of these 5 conditions. For
the EO, fixed floor condition, postvibration percentage equili-
brium scores at week 5 were significantly lower (P < .05) or
poorer than scores at pre- and post-week 1 and pre-week 5. For
the EO, fixed surroundings and floor sways condition, postvibra-
tion percentage equilibrium scores at week 5 were significantly
lower (P < .05) or poorer than scores at pre- and post-week 1, but
not different from previbration week 5 and previbration week 5
scores which were significantly lower (P < .05) than previbration
week 1 scores. Scores for previbration week 5 were significantly
greater or better (P < .05) than scores at previbration week 1 but
not different from postvibration scores week 1 or week 5 for the
EC, fixed surroundings and floor sways condition. Scores post-
vibration week 5 were significantly (P < .05) lower or poorer
than postvibration scores at week 1, and finally previbration
scores at week 5 were significantly (P < .05) greater than both
pre- and postvibration score week 1 for the EO, both surround-
ings and floor sway condition.
Discussion
This study investigated the acute and chronic effects of WBV
exposure on balance, postural control, and mobility in women
with MS. To the best of our knowledge, this is the first study to
examine the acute effects of WBV in women with MS; how-
ever, a limited number of studies have investigated the chronic
effects of WBV training on balance in patients with MS with
conflicting results. The main findings of the current investiga-
tion were that neither acute nor chronic WBV exposure once a
week for 5 weeks improved balance, postural control, or mobi-
lity in women with MS.
Acute Responses
Essentially, there were no significant main effects for group
and time nor significant group  time interactions for any of
the outcome variables at week 1 with only 3 exceptions. There
was a significant group effect for the ADP, toes up condition (P
¼ .049), with the CON group had significantly lower or better
scores than the WBV group across both time points. There also
were 2 significant main effects for time, the first being for the
ADP, toes up condition (P ¼ .003), which found postscores
significantly lower or better than prescores for both groups and
for the TW test, speed score (P ¼ .003) which decreased from
pre- to postvibration.
At week 5, acute responses were only assessed by the ADP
and SOT and results were similar to the findings at week 1,
with no significant main effects for group and no significant
group  time interactions. There were 3 variables (1 ADP
variable and 2 SOT variables) that had significant main effects
for time (toes up condition of the ADP, P ¼ .016, and EO with
fixed floor, P¼ .002, and EC with surroundings sway and fixed
floor, P ¼ .0090, conditions for the SOT).
As mentioned earlier, there was only one previous study
that assessed acute responses to WBV in patients with MS,
and our mobility results (acute responses at week 1) are sim-
ilar to those reported by Schuhfried,13 who also found no
significant differences between a WBV and a passive CON
group for the TUG test, measured 15 minutes following an
acute bout of WBV.
Our findings also indicated that acute exposure to WBV
did not improve balance or postural stability. Although there
are no studies in patients with MS for these outcomes, studies
in patients with stroke reported improvements in ambulation
and postural control after acute exposure to WBV. Chan
et al27 exposed patients with stroke to two, 10-minute periods
of vibration (vertical vibrations at 12 Hz and 4 mm amplitude)
and reported decreases in ankle spasticity and increased
ambulatory capacity. van Nes et al24 used 4 vibration bouts
of 45 seconds each separated by 1-minute rest periods (30 Hz
Figure 2. Chronic effects of WBV exposure on the sway energy scores
of the ADP (lower scores indicate greater stability). ADP indicates
Adaptation Test; WBV, whole-body vibration; CON, control condition.
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and 3 mm amplitude) and reported promising results for
improving proprioceptive control of posture in patients with
stroke. Our protocol (five, 30-second bouts of vibration, 30
Hz and 2-4 mm amplitude, 1-minute rest intervals between
bouts) was very similar to the van Nes et al’s24 protocol but
substantially lower in amplitude compared to the Chan
et al’s27 study.
Chronic Responses
As mentioned earlier, only the ADP and SOT were used to
examine the chronic effects of WBV after 5 weeks of vibra-
tion exposure. Exposure to the chronic use of WBV (once a
week for 5 weeks) did not improve balance or postural control
for any of the assessment variables. These results are consis-
tent with the previous literature that also examined WBV in
patients with MS. Alguacil Diego et al28 used the SOT to
assess the impact of 5 consecutive days of WBV exposure
on participants’ postural control. Similar to our findings, the
authors observed that 5 days of WBV (5 bouts of 1-minute
exposures separated by 1-minute rest periods at a frequency of
6 Hz and 3 mm amplitude) did not improve postural control in
patients with MS.
It is possible that more bouts of WBV are needed in order to
elicit significant improvements in balance and postural control
in individuals with MS. In this regard, Wolfsegger14 submitted
18 patients with MS to 3 weeks of WBV training performed 3
times per week instead of 1, as in the current investigation.
Figure 3. Chronic effects of WBV exposure on SOT scores (higher scores indicate greater stability). *Significantly different from week 1
(P < .05). SOT indicates Sensory Organization Test; WBV, whole-body vibration; CON, control condition.
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However, as reported in the current study, WBV vibration was
not efficient at improving physical function in patients mildly
affected with MS. In another study performed over a longer
period of time (20 weeks), Broekmans et al18 investigated
patients with MS who performed static and dynamic exercises
on a vibration platform (25-45 Hz, 2.5 mm amplitude, 5 train-
ing sessions per 2-week cycle) in which the training volume
and intensity was progressively increased over time. They did
not observe any significant improvements in muscle perfor-
mance or functional capacity following the 20-week period
of WBV training. Although the current study did not assess
muscle performance, our results are similar with though from
Broekmans et al18 in terms of no significant chronic changes
post-WBV training in patients with MS.
Even though chronic WBV training did not induce any
positive adaptations in patients with MS in the current inves-
tigation, previous studies have reported different results in
other populations. The ability to compare our results with
these studies is warranted, considering that patients with
MS display many physical limitations that are similar to those
observed in the elderly patients and in patients with stroke.
Considering this, Bruyere et al29 demonstrated significant
improvements in balance and mobility in nursing home resi-
dents exposed to 6 bouts of WBV training. The training pro-
tocol involved 3 visits per week for 6 weeks with a protocol of
4 bouts of 1-minute vibrations separated by 90 seconds of rest
at a frequency of 10 Hz and 3 mm amplitude for the first and
third bouts and a frequency of 26 Hz and 7 mm amplitude for
the second and fourth bouts. However, these results may differ
from our study due to the fact that the study by Bruyere et al29
used multiple visits over 6 weeks and much larger amplitudes
than most other studies and their vibration protocol was in
combination with physical therapy. In another study, Torvi-
nen et al30 submitted 66 young participants to a 4-month
WBV training period in which they performed light exercises
during different bouts of WBV, 3 to 5 times per week. During
the first 2 weeks of the study, the duration of the vibration was
2 minutes, at a frequency of 25 Hz for the first minute and 30
Hz for the second minute. Then, over the next month and a
half, the duration of the vibration was 3 minutes at frequencies
of 25 Hz/60 s, 30 Hz/60 s, and 35 Hz/60 s. Finally, for the last
2 months, the length of exposure was 4 minutes, at frequen-
cies of 25 Hz/60 s, 30 Hz/60 s, 35 Hz/60 s, and 40 Hz/60 s.
The amplitude of the vertical vibration was 2 mm. Interest-
ingly, even though the WBV training increased muscular
power and strength in the participants, there were no changes
in balance, similar to our findings. An important point is that
the direct effects of WBV in this study cannot be determined
given that patients also performed exercise while receiving
the vibration stimulus, which also makes it difficult to com-
pare these findings with those from the present study since our
participants were exposed to session of WBV without per-
forming any exercises. We also observed a large variability
across participants in our study, which indicates that the
response to WBV in MS may be affected by the severity of
the disease. Therefore, we encourage future studies to test the
Table 6. Chronic Effects of WBV Exposure on the ADP and SOT.
Variable Exp. n
Week 1 Week 5
Group Time Group  TimePre Post Pre Post
ADP TU (SES) WBV 12 66.5 (22.49) 58.50 (14.97)a 48.75 (11.73)a 46.42 (11.15)a P ¼ .068 P < .001 P ¼ .089
CON 8 51.63 (10.41) 44.00 (7.98)a 44.50 (12.94)a 37.13 (42.70)a Z2p ¼ .17 Z2p ¼ .53 Z2p ¼ .11
ADP TD (SES) WBV 12 49.25 (15.66) 46.75 (10.83) 45.50 (9.32) 43.25 (9.37) P ¼ .201 P ¼ .245 P ¼ .857
CON 9 43.22 (13.54) 39.11 (10.28) 41.67 (12.42) 39.11 (9.27) Z2p ¼ .08 Z2p ¼ .07 Z2p ¼ .01
SOT EO (%) WBV 12 91.83 (6.48) 92.5 (6.17) 93.67 (2.46) 87.50 (10.70)a,b,c P ¼ .577 P < .001 P ¼ .929
CON 93.89 (3.55) 94.11 (3.14) 94.78 (2.59) 88.22 (8.35)a,b,c Z2p ¼ .02 Z2p ¼ .35 Z2p < .01
SOT EC (%) WBV 12 87.75 (8.87) 88.00 (12.30) 89.75 (6.30) 89.33 (6.91) P ¼ .755 P ¼ .688 P ¼ .891
CON 9 90.00 (6.34) 88.56 (4.98) 89.78 (5.67) 89.78 (5.67) Z2p < .01 Z
2
p ¼ .03 Z2p ¼ .01
SOT FL EO (%) WBV 11 79.83 (9.23) 84.55 (6.30) 72.73 (6.47)a 67.27 (11.41)a,b P ¼ .519 P < .001 P ¼ .661
CON 8 82.12 (8.06) 81.00 (15.57) 67.13 (7.75)a 66.63 (14.89)a,b Z2p ¼ .03 Z2p ¼ .43 Z2p ¼ .04
SOT FL EC (%) WBV 11 64.55 (9.47) 66.73 (9.51) 72.55 (9.02)a 70.23 (9.61) P ¼ .722 P ¼ .012 P ¼ .748
CON 7 61.86 (9.14) 67.86 (7.56) 72.71 (11.00)a 66.14 (17.66) Z2p < .01 Z
2
p ¼ .20 Z2p ¼ .03
SOT SUR (%) WBV 12 87.25 (14.89) 88.25 (7.42) 88.00 (7.63) 83.42 (9.14)b P ¼ .762 P ¼ .003 P ¼ .729
CON 9 88.67 (8.25) 91.22 (3.27) 89.33 (6.46) 82.00 (13.50)b Z2p < .01 Z
2
p ¼ .21 Z2p ¼ .02
SOT SUR-FL (%) WBV 12 66.33 (16.43) 66.75 (12.82) 92.58 (4.78)a,b 89.08 (30.66) P ¼ .242 P < .001 P ¼ .153
CON 7 66.29 (14.26) 62.29 (14.21) 94.86 (3.18)a,b 69.00 (12.64) Z2p ¼ .08 Z2p ¼ .43 Z2p ¼ .10
Abbreviations: WBV, whole-body vibration; CON, control; ADP, Adaptation Test—lower scores indicate greater balance; TU, toes up; TD, toes down; SES, sway
energy score; SOT, Sensory Organization Test—higher scores indicate greater stability; EO, eyes open; EC, eyes closed; SUR, surroundings sway; FL, floor sways;
SUR-FL, both floor and surroundings sway.
aSignificantly different from pre at week 1 (P < .05).
bSignificantly different from post at week 1 (P < .05).
cSignificantly different from pre at week 5 (P < .05).
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effects of WBV in patients with MS at different levels of
disability or in more restrictive age groups.
Santos-Filho et al31 also reported conflicting results based
on a variety of studies that were examined in a systematic
review of the literature dealing with the possible benefits of
WBV in patients with stroke. These authors suggest that the
possible reasons for the varied include a variety of WBV expo-
sure times, different clinical characteristics of the patients from
the different studies, and the length of time elapsed from the
onset of the stroke. In another study on patients with stroke,
Pang et al32 reported that 15 min/d, 3 d/wk for 8 weeks of WBV
had no extra beneficial effects on muscular strength or bone
turnover rates compared to an exercise-only group, but knee
spasticity did improve for the WBV-only group. In this study,
patients with stroke performed exercises (weight shifting,
squats, lunges, standing on one leg) while receiving 6 bouts
of the vibration stimulus that ranged from 20 to 30 Hz, from
0.6 to 0.44 amplitudes, and 1.5 to 2.5 minutes across the length
of the study. They concluded that the protocol was safe and
feasible but provided no substantial benefits compared to
dynamic exercises in patients with stroke with mild-to-
moderate motor impairments.
Tihanyi et al33 examined the effects of a 4-week vibration
protocol 3 times per week (6 bouts of vibration at a frequency
of 20 Hz and 5 mm amplitude with each bout separated by 1
minute of rest) in patients with stroke. They reported signifi-
cant improvements in voluntary force production and muscle
activation of the quadriceps and concluded that a relatively
short-term training program of WBV (4 weeks) at medium
frequencies (20 Hz) was as effective as longer duration WBV
training programs (more than 2 months) at high frequencies
(26-40 Hz).
In contrast to patient with stroke findings, 2 studies in the
elderly patients (older than 60 years) reported improved bal-
ance and a reduction in the risk of falls following a WBV
intervention of 3 months34 and 18 months.35 Cheung et al34
utilized the Galileo 900 to induce the vibration stimulus that
was at a frequency of 20 Hz with feet placed at the second
position (amplitude between 0 and 5.3 mm). Patients were
independent living and received the stimulus 3 min/d,
3 d/wk, for 3 months. They reported significant improvements
in stability as indicated by the LOS test and functional reach
test. One limitation of this study was that activity levels for the
participants outside the training protocol were assessed by self-
report. Leung et al35 also studied independent living partici-
pants older than 60 years who stood straight legged on the
vibration platform for 20 min/d, 5 d/wk, for 18 months (vertical
vibrations at a frequency of 35 Hz, 0.3 g). Significant improve-
ments in reaction time, movement velocity, and maximum
excursion of balancing ability were reported along with a sig-
nificant increase in quadriceps muscle strength. Once again,
activity outside the training program was not directly assessed.
The current study is not without limitations. First, only
female participants were included; thus, our findings cannot
be extended to men with MS. Also our sample sizes for both
groups were small with not all patients completing all testing
sessions. Additionally, there was a large age range in our sam-
ple (18-64 years of age), which could impact our outcome
measures, not only because of normal age-related changes that
one might expect in balance, postural control, and mobility but
also because of the length of time that each participant has
spent with their diagnosis of MS. One problem that we had
to address when designing the vibration protocol for this study
was the uncertainty of the WBV intervention and safety issues
that could have arisen with a group of patients with MS, which
could have included exacerbation of their symptoms, increased
muscle weakness, or increased fatigue, since there is a paucity
of published findings from which to base our protocols on.
We recommend that future studies increase WBV dose such
as increasing the exposure times to at least 1 minute and to
increase the number of bouts to 5 or 6 during acute sessions and
to increase the frequency of sessions per week to either daily
sessions or at minimum 3 times per week for at least 6 to
8 weeks to better study the chronic effects of WBV. Addition-
ally, other patient populations that might benefit from WBV
exposure should be investigated and these could include
patients with stroke and patients with other neurodegenerative
diseases, such as Parkinson disease. Finally, we would also
suggest that future studies should combine WBV with some
sort of resistance exercise to determine whether there may be
additive effects of WBV to the benefits of an exercise inter-
vention to enhance positive adaptations.
Based on the findings from this study, we concluded that
neither acute nor chronic WBV exposure resulted in significant
improvements in balance, postural stability, or mobility in
women with MS, but additional studies are needed.
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váth M. Low resonance frequency vibration affects strength of paretic
and non-paretic leg differently in patients with stroke. Acta Physiol
Hung. 2010;97(2):172-182. doi:10.1556/APhysiol.97.2010.2.3.
34. Cheung WH, Mok HW, Qin L, Sze PC, Lee KM, Leung KS.
High-frequency whole-body vibration improves balancing ability
in elderly women. Arch Phys Med Rehabil. 2007;88(7):852-857.
doi:10.1016/j.apmr.2007.03.028.
35. Leung KS, Li CY, Tse YK, et al. Effects of 18-month low-
magnitude high-frequency vibration on fall rate and fracture risks
in 710 community elderly—a cluster-randomized controlled trial.
Osteoporos Int. 2014;25(6):1785-1795. doi:10.1007/s00198-014-
2693-6.
Freitas et al 13
